Corrigendum: Contribution of classical end-joining to PTEN inactivation in p53-mediated glioblastoma formation and drug-resistant survival (Nature Communications, (2017), 8, 1, (14013), 10.1038/ncomms14013)

Youn Jung Kang; Barbara Balter; Eva Csizmadia; Brian Haas; Himanshu Sharma; Roderick Bronson; Catherine T. Yan

ArticleOPEN ACCESS

Corrigendum: Contribution of classical end-joining to PTEN inactivation in p53-mediated glioblastoma formation and drug-resistant survival (Nature Communications, (2017), 8, 1, (14013), 10.1038/ncomms14013)

Nature Communications

DOI: 10.1038/ncomms15795

2Citations

10Readers

Abstract

‘In the References section of this Article, the citation listed as reference 17 is incorrect, and should have referred to the following paper: Forbes, S. A. et al. COSMIC: exploring the world's knowledgeof somatic mutations in human cancer.

Cite

CITATION STYLE

APA

Kang, Y. J., Balter, B., Csizmadia, E., Haas, B., Sharma, H., Bronson, R., & Yan, C. T. (2017, August 30). Corrigendum: Contribution of classical end-joining to PTEN inactivation in p53-mediated glioblastoma formation and drug-resistant survival (Nature Communications, (2017), 8, 1, (14013), 10.1038/ncomms14013). Nature Communications. Nature Research. https://doi.org/10.1038/ncomms15795

Corrigendum: Contribution of classical end-joining to PTEN inactivation in p53-mediated glioblastoma formation and drug-resistant survival (Nature Communications, (2017), 8, 1, (14013), 10.1038/ncomms14013)

Abstract

Cite

Register to see more suggestions